G. Petrof

发表

Mutations in GRHL2 Result in an Autosomal-Recessive Ectodermal Dysplasia Syndrome

M. Simpson, J. R. McMillan, M. Akiyama, 2014, American journal of human genetics.

Cell therapy in dermatology.

J. McGrath, G. Petrof, A. Abdul‐Wahab, 2014, Cold Spring Harbor Perspectives in Medicine.

Bone marrow transplantation in epidermolysis bullosa.

J. McGrath, G. Petrof, A. Abdul‐Wahab, 2012, Immunotherapy.

University of Dundee Mutations in GRHL 2 result in an autosomal-recessive ectodermal dysplasia syndrome

M. Simpson, J. R. McMillan, M. Akiyama, 2022 .

A Phase I/II open-label trial of intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa.

J. R. McMillan, J. McGrath, C. Ainali, 2019, Journal of the American Academy of Dermatology.

Characteristics of children with Netherton syndrome: a review of 21 patients

J. Mellerio, M. Laimer, G. Petrof, 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

Establishing an appropriate level of vitamin D supplementation in paediatric patients with recessive dystrophic epidermolysis bullosa

G. Petrof, A. Martinez, N. Yerlett, 2022, Clinical and experimental dermatology.

Infliximab for the treatment of psoriasis in the U.K.: 9 years’ experience of infusion reactions at a single centre

G. Petrof, J. Barker, C. Smith, 2012, The British journal of dermatology.

Adipocytes in Skin Health and Disease

F. Watt, A. Christiano, G. Petrof, 2014 .

Clinical features and WNT10A mutations in seven unrelated cases of Schöpf–Schulz–Passarge syndrome

J. McGrath, J. Mellerio, E. Wedgeworth, 2014, The British journal of dermatology.

Prevalence of and risk factors for nutritional deficiency and food allergy in a cohort of 21 patients with Netherton syndrome

J. Mellerio, G. Petrof, C. Prodinger, 2023, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

A systematic review of the literature on the treatment of pityriasis rubra pilaris type 1 with TNF‐antagonists

W. Griffiths, G. Petrof, N. Almaani, 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

The natural history of laryngo‐onycho‐cutaneous syndrome: A case series of six pediatric patients and literature review

J. McGrath, J. Mellerio, M. Laimer, 2021, Pediatric dermatology.

Clinical trial of ABCB5+ mesenchymal stem cells for recessive dystrophic epidermolysis bullosa

J. Tolar, J. McGrath, C. Ebens, 2021, JCI insight.

Fibroblast cell therapy enhances initial healing in recessive dystrophic epidermolysis bullosa wounds: results of a randomized, vehicle‐controlled trial

J. McGrath, J. Mellerio, G. Petrof, 2013, The British journal of dermatology.

Otological complications in inversa type recessive dystrophic epidermolysis bullosa

J. Mellerio, G. Petrof, C. Skilbeck, 2021, Clinical and experimental dermatology.

Activating CARD14 Mutations Are Associated with Generalized Pustular Psoriasis but Rarely Account for Familial Recurrence in Psoriasis Vulgaris.

J. McGrath, R. Trembath, F. Capon, 2015, The Journal of investigative dermatology.

To what extent do disease severity and illness perceptions explain depression, anxiety and quality of life in hidradenitis suppurativa?

J. Weinman, G. Petrof, M. Turner, 2018, The British journal of dermatology.

A systematic review of the literature on the treatment of pityriasis rubra pilaris type 1 with TNFantagonists

W. Griffiths, G. Petrof, N. Almaani, 2012 .

Retrospective review of 18 British South Asian women with frontal fibrosing alopecia

S. Holmes, G. Petrof, M. Harries, 2018, International journal of dermatology.

CWCMR_A_172193 99..107

G. Petrof, Craig McDonald, A.E. Martinez, 2019 .

Schöpf–Schulz–Passarge syndrome resulting from a homozygous nonsense mutation, p.Cys107X, in WNT10A

G. Petrof, J. Lai-Cheong, K. Fong, 2011, The Australasian journal of dermatology.

Serum levels of high mobility group box 1 correlate with disease severity in recessive dystrophic epidermolysis bullosa

J. McGrath, J. Mellerio, G. Petrof, 2013, Experimental dermatology.

Epithelial inflammation resulting from an inherited loss-of-function mutation in EGFR

M. Simpson, J. R. McMillan, M. Akiyama, 2014, The Journal of investigative dermatology.

Potential of Systemic Allogeneic Mesenchymal Stromal Cell Therapy for Children with Recessive Dystrophic Epidermolysis Bullosa.

J. Tolar, J. McGrath, P. Veys, 2015, The Journal of investigative dermatology.

Infantile haemangioma presenting in combination with a cerebriform naevus sebaceous on the scalp

G. Petrof, L. Solman, A. Martinez, 2021, Clinical and experimental dermatology.

The epidemiology of epidermolysis bullosa in England and Wales: data from the national epidermolysis bullosa database *

J. McGrath, J. Mellerio, G. Petrof, 2021, The British journal of dermatology.

Prevalence and treatment of vitamin K deficiency in paediatric patients with recessive dystrophic epidermolysis bullosa‐severe subtype

G. Petrof, N. Yerlett, A. Martinez, 2021, Skin health and disease.

Biallelic TUFT1 variants cause woolly hair, superficial skin fragility and desmosomal defects.

S. Banka, J. Mellerio, K. Chandler, 2022, The British journal of dermatology.

The impact of using a multistrain probiotic supplement on gastrointestinal function in children and adolescents with severe recessive dystrophic epidermolysis bullosa.

G. Petrof, N. Yerlett, M. Bageta, 2022, Clinical and experimental dermatology.

Disseminated Congenital Malignant Rhabdoid Tumor Misdiagnosed as Multiple Congenital Hemangiomas.

G. Petrof, F. Mussai, I. Colmenero, 2019, Journal of pediatric hematology/oncology.

Clinical trial of ABCB5 + mesenchymal stem cells for recessive dystrophic epidermolysis bullosa

J. Tolar, C. Ebens, A. Hovnanian, 2021 .

Epidermolysis bullosa acquisita: a case series of three paediatric patients

J. Mellerio, E. Calonje, G. Petrof, 2022, Clinical and experimental dermatology.